Coronary disease & ACSSecondary analysis

Outcomes According to Coronary Disease Complexity and Optimal Thresholds to Guide Revascularization Approach

JACC Cardiovasc IntervPublished

  • Secondary analysis of the FAME 3 randomised trial

Authors' conclusion

In patients with MVD without left main disease, PCI and CABG outcomes remain comparable up to SS values in the mid- rather than low 20s, which allows the identification of a greater proportion of patients in whom PCI may be a reasonable alternative to CABG.

Study context

Population
Patients with multivessel disease (MVD) without left main diseaseof 1,500 in FAME 3
Participants
1,444 patients
Comparison
Percutaneous coronary intervention (PCI) vs coronary artery bypass grafting (CABG) by SYNTAX score
  • PCIn = 734
  • CABGn = 710reference
Primary endpoint
Primary endpoint (not specified in the abstract)
Follow-up
3-year

Primary result

As reported in the abstract

3-year primary endpoint, CABG vs PCI by SS · 3 years

Outcomes comparable between CABG and PCI for SYNTAX score (SS) ≤24

P = 0.332

Patients below SS ≤24 threshold

44%

Patients below conventional SS threshold ≤22

32%

Significant interactions between revascularization strategy and SS for 1- and 3-year composite endpoints

P for interaction <0.05 for all

Further findings

Mean SYNTAX score

Mean SS
25.9 ± 7.1

Association of SS with outcomes

SS associated with 1-year MACCE among PCI patients and 3-year death, MI and stroke among CABG patients

Original publication

Outcomes According to Coronary Disease Complexity and Optimal Thresholds to Guide Revascularization Approach. JACC Cardiovasc Interv. Published 26 August 2024. doi:10.1016/j.jcin.2024.06.003

Summarised from the published abstract; every number is checked against it